𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primary cutaneous CD8+ small/medium-sized pleomorphic T-cell lymphoma, ear-type: a unique cutaneous T-cell lymphoma with a favourable prognosis

✍ Scribed by C. Géraud; S. Goerdt; C.D. Klemke

Book ID
108671515
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
187 KB
Volume
164
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isolation of a CD8αα+ CD4– tumour T-cell
Isolation of a CD8αα+ CD4– tumour T-cell clone with cytotoxic activity from a CD4+ CD8– cutaneous T-cell lymphoma
✍ M. Nikolova; H. Echchakir; J. Wechsler; L. Boumsell; A. Bensussan; M. Bagot 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

## Background: We have previously established tumour t-cell lines, both from the skin and from the blood of patients with a cutaneous t-cell lymphoma (ctcl). in one patient, the tumour cells and the derived cell lines had a cd3+ cd4+ cd8- phenotype and a trisomy of chromosome 7. they expressed thre

CD8+ cutaneous T-cell lymphoma successfu
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: A case report and review of the literature
✍ Srivalli Gopaluni; Raiza Perzova; Lynn Abbott; Ramsey Farah; Anthony Shrimpton; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Abstract CD8+ cutaneous T‐cell lymphoma (CTCL) is a relatively rare subset of the non‐Hodgkins lymphomas. Bexarotene has been FDA‐approved for the treatment of CTCL, but previous studies have been conducted on CD4+ CTL and there have been no reports about its use in CD8+ CTCL. Herein, we report